Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Lana Mudarris
Observed institution:
Bristol-Myers Squibb (United States)
OpenAlex ID:
A5064026265
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
2023
·
Milind Y. Desai
, Anjali Owens
, et al.
·
JAMA Cardiology
·
172
PDF
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results From VALOR-HCM
2024
·
Milind Y. Desai
, Kathy Wolski
, et al.
·
Circulation
·
79
The Pharmacology, Efficacy, and Safety of Rivaroxaban in Obese Patient Populations
2020
·
Veronica Ashton
, Lana Mudarris
, et al.
·
American Journal of Cardiovascular Drugs
·
15
PDF
Correction to: Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction: Week 128 Results from VALOR-HCM
2025
·
Milind Y. Desai
, Kathy Wolski
, et al.
·
Circulation
·
4
Show more works
View as search
Works count:
4
Citation count:
269
H-index:
4
I10-index:
3
Year
Topic
Type
